• EMAIL
  • PRINT
  • PDF
  • Bookmark and Share

Education

  • J.D., Suffolk University Law School, 2007
  • Ph.D., Massachusetts Institute of Technology, Biochemistry, 1997
  • M.A., Columbia University, Chemistry, 1990
  • B.S., Trinity College, Chemistry, Valedictorian, 1988

Bar Admissions

  • Massachusetts
  • U.S. Patent & Trademark Office

Memberships & Affiliations

Boston Patent Law Association

Women's Bar Association

Jill Ann Mello, Ph.D.

  • |
Partner
  • T: 617.449.6563
    F: 617.607.9124

Dr. Mello has over 17 years of experience in intellectual property law. Her practice focuses in the area of life sciences, and includes particular experience in the technology areas of cancer therapeutics, antibodies, immunology, human cell therapeutics, microbiology and the microbiome, biomarkers and molecular diagnostics, nucleic acid therapeutics, small molecule therapeutics, drug formulations, drug discovery platform technologies and bioinformatics.

Dr. Mello has extensive experience assisting clients in the strategic development and management of complex patent portfolios worldwide that are aligned with their business objectives. She assists clients in the preparation of patentability, infringement and freedom-to-operate analysis and opinions, with due diligence evaluations, as well as with the preparation and negotiation of collaboration and license agreements. Dr. Mello has experience with involvement in opposition proceedings before the European Patent Office. She represents a wide array of clients including early stage companies, small and mid-size biotechnology companies, pharmaceutical corporations, academic institutions, and venture-capital firms.

Prior to joining the firm, Dr. Mello earned her Ph.D. in Biochemistry from the Massachusetts Institute of Technology. Dr. Mello’s doctoral thesis focused on elucidating the therapeutic mechanisms of the anticancer drug cisplatin. Following her Ph.D., Dr. Mello carried out postdoctoral research on chromatin dynamics at the Curie Institute in Paris, France, for which she was the recipient of a Chateaubriand fellowship from the French government and a grant awarded by Aventis. Her work has been presented at international scientific meetings, and has been published in leading peer reviewed journals.